Public Market Listing
1093HKEX
Live quotes, historical charts, and market capitalization for CSPC Pharmaceutical Group are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(11 total)
11Total Assets
0Approved
8Phase 3 / Filed
3Phase 1–2 / Early
9Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | Serotonin/norepinephrine transporterSmall molecule | Major Depressive Disorder | |
DBPR108No recent activity | Phase 3 | DPP-4Small molecule | Type 2 Diabetes |
| Phase 3 | HER2 (biparatopic — extracellular domains II and IV)Antibody–drug conjugate | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | FLT3 / EGFR / ABL (also Fyn, Hck, Lck, Lyn, Ret, Yes)Small molecule | Acute Myeloid Leukemia | |
| Phase 3 | PCSK9RNA / oligonucleotide | Atherosclerotic Cardiovascular Disease | |
| Phase 3 | Angiotensin II type 1 receptor / L-type calcium channel (dual)Small molecule | Hypertension | |
| Phase 3 | TYK2Small molecule | Psoriasis | |
| Phase 3 | GLP-1 receptorProtein / enzyme therapeutic | Obesity | |
| Phase 2 | LPA gene / apolipoprotein(a)RNA / oligonucleotide | Atherosclerotic Cardiovascular Disease | |
| Phase 2 | ANGPTL3RNA / oligonucleotide | Atherosclerotic Cardiovascular Disease | |
| Preclinical / Unstaged | Dopamine D2 and serotonin 5-HT2A receptors (antagonist)Small molecule | Schizophrenia |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.